The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Mortality in the 4-Year Trial of Tiotropium (UPLIFT) in Patients with Chronic Obstructive Pulmonary Disease
Abstract
Abstract Rationale In the 4-year UPLIFT trial, tiotropium improved lung function and health-related quality of life and decreased exacerbations compared with usual respiratory medications except inhaled anticholinergics in patients with chronic obstructive pulmonary disease (COPD). Mortality and its causes was a secondary endpoint in UPLIFT. Objectives We describe the effect of tiotropium on survival and analyze differences between mortality during treatment and during follow-up of discontinued patients. Methods This study involved a randomized, double-blind trial comparing tiotropium with placebo in patients with COPD (≥40 yr of age; postbronchodilator FEV1 ≤70%; FEV1/FVC ≤70%). Mortality was evaluated during treatment and with follow-up of discontinued patients. Cause of death was adjudicated by an endpoint committee. Measurements and Main Results A total of 5,993 patients were randomized, 3,006 to placebo and 2,987 to tiotropium. While patients were receiving treatment, there were 792 deaths, with a lower risk in the tiotropium group (hazard ratio, 0.84; 95% confidence interval [CI], 0.73–0.97). Statistical significance was observed at the end of the protocol-defined treatment period (P = 0.034) but not 30 days thereafter (P = 0.086). Adjustment by GOLD stage, sex, age, baseline smoking behavior, and baseline respiratory medications subgroups did not alter the results of the analysis. The most common causes of death adjudicated by an independent end-point committee were lower respiratory, cancer, general disorders, and cardiac disorders. The hazard ratios for lower respiratory and cardiac mortality during treatment were 0.86 (95% CI, 0.68–1.09) and 0.86 (95% CI, 0.75–0.99), respectively. Conclusions Treatment with tiotropium over 4 years is associated with decreased mortality, with the effect being most prominent in the cardiac and respiratory systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Standardization of Spirometry, 1994 Update. American Thoracic Society.
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663792 · Cited by 6,594
Global Initiative for Chronic Obstructive Lung Disease
Gerald, L. B., & Bailey, W. C. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00004 · Cited by 5,830
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Self-citationJones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035
The St George's Respiratory Questionnaire
Jones, P. W., Quirk, F. H., & Baveystock, C. M. (1991) · Respiratory Medicine · doi:10.1016/s0954-6111(06)80166-6 · Cited by 2,683
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
What is meant by intention to treat analysis? Survey of published randomised controlled trials
Hollis, S., & Campbell, F. (1999) · BMJ · doi:10.1136/bmj.319.7211.670 · Cited by 2,160
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa030287 · Cited by 2,071
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
Tashkin, D. P., Celli, B., Senn, S., Burkhart, D., Kesten, S., Menjoge, S., & Decramer, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805800 · Cited by 1,604
Self-citationAnthonisen, N. R. (1994) · JAMA · doi:10.1001/jama.1994.03520190043033 · Cited by 1,341
(1981) · The Lancet · doi:10.1016/s0140-6736(81)91970-x · Cited by 884
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
Casaburi, R., Mahler, D. A., Jones, P. W., Wanner, A., San Pedro, G., ZuWallack, R. L., Menjoge, S. S., Serby, C. W., & Witek, T. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00269802 · Cited by 881
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD
O'Donnell, D. E., Flüge, T., Gerken, F., Hamilton, A., Webb, K., Aguilaniu, B., Make, B., & Magnussen, H. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00116004 · Cited by 859
Wedzicha, J. A., Calverley, P. M. A., Seemungal, T. A., Hagan, G., Ansari, Z., & Stockley, R. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-973oc · Cited by 827
Seneff, M. G. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530230038027 · Cited by 593
Zaroff, J. G., Rosengard, B. R., Armstrong, W. F., Babcock, W. D., D’Alessandro, A., Dec, G. W., Edwards, N. M., Higgins, R. S., Jeevanandum, V., Kauffman, M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000025587.40373.75 · Cited by 495
Buist, A. S., & Connett, J. E. (1993) · Chest · doi:10.1378/chest.103.6.1644a · Cited by 483
Domingo-Salvany, A., Lamarca, R., Ferrer, M., Garcia-Aymerich, J., Alonso, J., Félez, M., Khalaf, A., Marrades, R. M., Monsó, E., Serra-Batlles, J., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2112043 · Cited by 411
Maltais, F., Hamilton, A., Marciniuk, D., Hernandez, P., Sciurba, F. C., Richter, K., Kesten, S., & O’Donnell, D. (2005) · Chest · doi:10.1378/chest.128.3.1168 · Cited by 305
Self-citationCelli, B., ZuWallack, R., Wang, S., & Kesten, S. (2003) · Chest · doi:10.1378/chest.124.5.1743 · Cited by 290
Self-citationVariables related to increased mortality following out-patient pulmonary rehabilitation
Gerardi, D., Lovett, L., Benoit-Connors, M., Reardon, J., & ZuWallack, R. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09030431 · Cited by 225
Lange, P., Nyboe, J., Appleyard, M., Jensen, G., & Schnohr, P. (1990) · Thorax · doi:10.1136/thx.45.8.579 · Cited by 217
Protective Effects of Tiotropium Bromide in the Progression of Airway Smooth Muscle Remodeling
Gosens, R., Bos, I. S. T., Zaagsma, J., & Meurs, H. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1249oc · Cited by 196
Cardiovascular Safety of Tiotropium in Patients With COPD
Celli, B., Decramer, M., Leimer, I., Vogel, U., Kesten, S., & Tashkin, D. P. (2010) · Chest · doi:10.1378/chest.09-0011 · Cited by 184
Self-citationPrognosis in Chronic Obstructive Pulmonary Disease: Results from Multicenter Clinical Trials
Anthonisen, N. R. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.3_pt_2.s95 · Cited by 176
Pooled Clinical Trial Analysis of Tiotropium Safety
Kesten, S., Jara, M., Wentworth, C., & Lanes, S. (2006) · Chest · doi:10.1378/chest.130.6.1695 · Cited by 171
Self-citationDecramer, M., Celli, B., Tashkin, D. P., Pauwels, R. A., Burkhart, D., Cassino, C., & Kesten, S. (2004) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-200026934 · Cited by 169
Self-citationMethodological issues in therapeutic trials of COPD
Suissa, S., Ernst, P., Vandemheen, K. L., & Aaron, S. D. (2008) · European Respiratory Journal · doi:10.1183/09031936.00098307 · Cited by 160
Raghu, G., Masta, S. E., Meyers, D., & Narayanan, A. S. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.1.95 · Cited by 153
Withdrawal From Treatment as an Outcome in the ISOLDE Study of COPD
Calverley, P. M. A., Spencer, S., Willits, L. R., Burge, P. S., & Jones, P. (2003) · CHEST Journal · doi:10.1378/chest.124.4.1350 · Cited by 121
Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro
Bühling, F., Lieder, N., Kühlmann, U. C., Waldburg, N., & Welte, T. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.06.009 · Cited by 107
Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts
Haag, S., Matthiesen, S., Juergens, U. R., & Racké, K. (2008) · European Respiratory Journal · doi:10.1183/09031936.00129307 · Cited by 90
Gershon, A. S., Wang, L., To, T. M., Luo, J., & Upshur, R. E. G. (2008) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550802237507 · Cited by 22
Cited by
Cardiovascular disease and COPD: dangerous liaisons?
Rabe, K. F., Hurst, J. R., & Suissa, S. (2018) · European Respiratory Review · doi:10.1183/16000617.0057-2018 · Cited by 410
Epidemiology and clinical impact of major comorbidities in patients with COPD
Smith, M., & Wrobel, J. (2014) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s49621 · Cited by 407
Tiotropium Respimat Inhaler and the Risk of Death in COPD
Wise, R. A., Anzueto, A., Cotton, D., Dahl, R., Devins, T., Disse, B., Dusser, D., Joseph, E., Kattenbeck, S., Koenen-Bergmann, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303342 · Cited by 333
Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease: Incidence and Predicting Factors
de Torres, J. P., Marín, J. M., Casanova, C., Cote, C., Carrizo, S., Cordoba-Lanus, E., Baz-Dávila, R., Zulueta, J. J., Aguirre-Jaime, A., Saetta, M., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0430oc · Cited by 304
Self-citationChronic obstructive pulmonary disease and comorbidities
Decramer, M., & Janssens, W. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(12)70060-7 · Cited by 291
Self-citation
Metadata
- Authors
- Celli, B., Decramer, M., Kesten, S., Liu, D., Mehra, S., & Tashkin, D. P.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11-15
- Volume
- 180
- Issue
- 10
- Pages
- 948-955
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2142633372
- Cited by
- 281
- References
- 35
- FWCI
- 22.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.